» Articles » PMID: 35455476

Special Issue "Anticancer Drugs 2021"

Overview
Publisher MDPI
Specialty Chemistry
Date 2022 Apr 23
PMID 35455476
Authors
Affiliations
Soon will be listed here.
Abstract

This Special Issue of is devoted to significant advances achieved in the field of Anticancer Drugs in 2021 [...].

Citing Articles

Bioactive Activities of the Phenolic Extract from Sterile Bracts of .

Fischer T, Marcondes A, Zardo D, Nogueira A, Calhelha R, Vaz J Antioxidants (Basel). 2022; 11(12).

PMID: 36552640 PMC: 9774675. DOI: 10.3390/antiox11122431.


Novel Strategies against Cancer: Dexibuprofen-Loaded Nanostructured Lipid Carriers.

Thiruchenthooran V, Switalska M, Bonilla L, Espina M, Garcia M, Wietrzyk J Int J Mol Sci. 2022; 23(19).

PMID: 36232614 PMC: 9570096. DOI: 10.3390/ijms231911310.

References
1.
Reis-Mendes A, Dores-Sousa J, Padrao A, Duarte-Araujo M, Duarte J, Seabra V . Inflammation as a Possible Trigger for Mitoxantrone-Induced Cardiotoxicity: An In Vivo Study in Adult and Infant Mice. Pharmaceuticals (Basel). 2021; 14(6). PMC: 8229902. DOI: 10.3390/ph14060510. View

2.
Imran M, Asdaq S, Khan S, Unnikrishnan Meenakshi D, Alamri A, Alsanie W . Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades. Pharmaceuticals (Basel). 2021; 14(8). PMC: 8400070. DOI: 10.3390/ph14080710. View

3.
Elrayess R, Abdel Aziz Y, Elgawish M, Elewa M, Yassen A, Elhady S . Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line. Pharmaceuticals (Basel). 2020; 14(1). PMC: 7823583. DOI: 10.3390/ph14010009. View

4.
Ana G, Kelly P, Malebari A, Noorani S, Nathwani S, Twamley B . Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1-1,2,4-triazoles and 1-(Diarylmethyl)-1-imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer. Pharmaceuticals (Basel). 2021; 14(2). PMC: 7926793. DOI: 10.3390/ph14020169. View

5.
Kovaleva K, Yarovaya O, Ponomarev K, Cheresiz S, Azimirad A, Chernyshova I . Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties. Pharmaceuticals (Basel). 2021; 14(5). PMC: 8147275. DOI: 10.3390/ph14050422. View